Form 4: Aurinia Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Matthew Maxwell Donley, EVP of Operations & Strategy at Aurinia Pharmaceuticals, sold 40,665 shares of common stock to cover tax withholding obligations related to vesting Restricted Stock Units.

Summary

• On March 6, 2024, Matthew Maxwell Donley, EVP, Ops & Strategy of Aurinia Pharmaceuticals Inc., sold 40,665 shares of common stock.
• The sale was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units granted on March 2, 2022, and March 2, 2023.
• The shares were sold at a weighted average price of $5.51, with individual transactions ranging from $5.475 to $5.755.
• Following the transaction, Donley directly owns 584,072 shares of Aurinia Pharmaceuticals Inc.

Sentiment

Score: 6

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sale is for tax obligations, which is a neutral event.

Industry Context

Executive share sales to cover tax obligations are a common occurrence and generally don't indicate a negative outlook for the company.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates